Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
HIV protease inhibitor
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
Viracept
|
| gptkbp:class |
protease inhibitors
|
| gptkbp:clinical_trial |
85%
|
| gptkbp:developed_by |
gptkb:Roche
|
| gptkbp:effective_date |
gptkb:1997
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nelfinavir
|
| gptkbp:ingredients |
C20 H27 N3 O5 S
|
| gptkbp:is_atype_of |
J05 A E02
|
| gptkbp:is_used_for |
treatment of HIV
|
| gptkbp:manager |
oral
|
| gptkbp:side_effect |
nausea
abdominal pain diarrhea rash |
| gptkbp:type_of |
159989-17-0
|
| gptkbp:bfsParent |
gptkb:Burroughs_Wellcome
|
| gptkbp:bfsLayer |
4
|